Similarly, upregulation of LINC01614 has been proposed as a prognostic indicator of survival in non-small cell lung cancer (NSCLC) [15], and LINC01614 knockdown inhibits lung adenocarcinoma progression [13]. Here, LINC01614 is linked to non-small cell lung carcinoma.